StockNews.AI
WALD
StockNews.AI
2 hrs

Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates

1. Waldencast will report earnings for Q2 and Q3 on November 24, 2025. 2. There will be no conference call for the earnings release. 3. The company is currently undergoing a strategic review. 4. Waldencast focuses on developing and scaling beauty brands. 5. A multi-brand platform aims to enhance market responsiveness.

0%Current Return
VS
0%S&P 500
$1.7811/12 07:34 AM EDTEvent Start

$1.7811/12 08:47 AM EDTLatest Updated
5m saved
Insight

FAQ

Why Neutral?

The lack of a conference call may indicate ongoing internal challenges, affecting investor confidence. Historically, similar circumstances have led to short-term stock price stagnation.

How important is it?

Earnings announcements typically carry weight, especially amid company restructuring efforts.

Why Short Term?

Immediate investor sentiment may waver due to the strategic review process, but the long-term vision appears sound.

Related Companies

LONDON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, provided additional details for its upcoming earnings release and conference call dates. The Company currently expects to issue Second Quarter Fiscal 2025 Results and Q3 2025 Financial Results on November 24, 2025. The Company does not plan to host a conference call with respect to these results given its ongoing strategic review.

About Waldencast plc

Founded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast's vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand's distinct DNA. The first step in realizing its vision was the business combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.

Contacts

Investors

ICR

Allison Malkin

waldencastir@icrinc.com

Media

ICR

Brittany Fraser/Alecia Pulman

Waldencast@icrinc.com



Primary Logo

Related News